NRP1 and neoplasm: Intriguingly, while NRPs can bind many tumor-suppressor semaphorins, they are in fact considered tumor-promoting molecules per se; thus, NRP1 targeting is gaining increasing interest for cancer therapy, independent of semaphorin functions 107,108.